chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 47.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Abdominal distension, Abscess drainage, Acute respiratory failure, Angiogram cerebral normal, Angiopathy
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 8/13/2022 Discharge Date: Sep 12, 2022  PRESENTING PROBLEM: Heart failure (HCC) [I50.9] Elevated troponin [R77.8] Acute on chronic combined systolic and diastolic congestive heart failure (HCC) [I50.43] Chronic kidney disease, stage 4 (severe) (HCC) [N18.4]   HOSPITAL COURSE: 48-year-old male admitted on 8/13/2022, with PMhx of combined heart failure, CAD post CABG, CKD stage 4, chronic obstructive pulmonary disease, PAD, type 2 diabetes, right 5th toe amputation, hypertension, hyperlipidemia.  Presented with worsening lower extremity swelling, abdominal swelling, shortness of breath and decreased urine output onset 1 week prior when he ran out of metolazone. Troponin was elevated but near baseline.  EKG showed similar changes to previous.  ProBNP markedly elevated. Chest x-ray showed pulmonary vascular congestion and cardiomegaly.  Creatinine increased from baseline.  No osteomyelitis on right foot.  He was stable on 2 L nasal cannula.  Admitted to medicine for further management.     Nephrology and Cardiology were consulted.  Attempted to diurese patient aggressively was IV Lasix, then Lasix drip, then Bumex and combination of other meds.  Did not show much progress and remained fluid overloaded.  Patient complained periodically of edematous and painful scrotum.  Urology was consulted for evaluation.  CT scan and ultrasound was negative for tissue infection or abscess.  Pain likely due to edema.  Per Nephrology, dialysis was started on August 22nd with uncertain final duration. Patient was discharged with arrangements for outpatient dialysis. His course was complicated by non-adherence to recommended low Na, fluid restricted diet.   Patient also tested positive for COVID on August 20th and developed acute hypoxic respiratory failure, treated with Decadron and remdesivir.  Also noted Staph epidermidis bacteremia at the same time, ID consulted and he was placed on empiric antibiotics, ultimately transitioned to vancomycin. TEE on 8/30 negative for endocarditis. ID recommending total 4 weeks of IV vancomycin, arranged to be given with outpatient dialysis with nephrology prescribing.   Patient developed an abscess on left forearm due to infiltrated IV, which was drained by general surgery without complication.   On 9/11, patient developed left eye blurry vision. CT head and CTA head were negative for etiology, ophthalmology consulted and diagnosed with vitreous hemorrhage, recommended outpatient follow up.    Patient was discharged in stable condition with arrangements for outpatient dialysis and vancomycin to be administered at dialysis.
Age: 47.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Blood creatinine increased, COVID-19, Cardiac failure, Cardiac failure acute, Cardiac failure congestive
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 8/13/2022 Discharge Date: Sep 12, 2022  PRESENTING PROBLEM: Heart failure (HCC) [I50.9] Elevated troponin [R77.8] Acute on chronic combined systolic and diastolic congestive heart failure (HCC) [I50.43] Chronic kidney disease, stage 4 (severe) (HCC) [N18.4]   HOSPITAL COURSE: 48-year-old male admitted on 8/13/2022, with PMhx of combined heart failure, CAD post CABG, CKD stage 4, chronic obstructive pulmonary disease, PAD, type 2 diabetes, right 5th toe amputation, hypertension, hyperlipidemia.  Presented with worsening lower extremity swelling, abdominal swelling, shortness of breath and decreased urine output onset 1 week prior when he ran out of metolazone. Troponin was elevated but near baseline.  EKG showed similar changes to previous.  ProBNP markedly elevated. Chest x-ray showed pulmonary vascular congestion and cardiomegaly.  Creatinine increased from baseline.  No osteomyelitis on right foot.  He was stable on 2 L nasal cannula.  Admitted to medicine for further management.     Nephrology and Cardiology were consulted.  Attempted to diurese patient aggressively was IV Lasix, then Lasix drip, then Bumex and combination of other meds.  Did not show much progress and remained fluid overloaded.  Patient complained periodically of edematous and painful scrotum.  Urology was consulted for evaluation.  CT scan and ultrasound was negative for tissue infection or abscess.  Pain likely due to edema.  Per Nephrology, dialysis was started on August 22nd with uncertain final duration. Patient was discharged with arrangements for outpatient dialysis. His course was complicated by non-adherence to recommended low Na, fluid restricted diet.   Patient also tested positive for COVID on August 20th and developed acute hypoxic respiratory failure, treated with Decadron and remdesivir.  Also noted Staph epidermidis bacteremia at the same time, ID consulted and he was placed on empiric antibiotics, ultimately transitioned to vancomycin. TEE on 8/30 negative for endocarditis. ID recommending total 4 weeks of IV vancomycin, arranged to be given with outpatient dialysis with nephrology prescribing.   Patient developed an abscess on left forearm due to infiltrated IV, which was drained by general surgery without complication.   On 9/11, patient developed left eye blurry vision. CT head and CTA head were negative for etiology, ophthalmology consulted and diagnosed with vitreous hemorrhage, recommended outpatient follow up.    Patient was discharged in stable condition with arrangements for outpatient dialysis and vancomycin to be administered at dialysis.
Age: 47.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Cardiomegaly, Chest X-ray abnormal, Chronic kidney disease, Computerised tomogram head normal, Computerised tomogram normal
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 8/13/2022 Discharge Date: Sep 12, 2022  PRESENTING PROBLEM: Heart failure (HCC) [I50.9] Elevated troponin [R77.8] Acute on chronic combined systolic and diastolic congestive heart failure (HCC) [I50.43] Chronic kidney disease, stage 4 (severe) (HCC) [N18.4]   HOSPITAL COURSE: 48-year-old male admitted on 8/13/2022, with PMhx of combined heart failure, CAD post CABG, CKD stage 4, chronic obstructive pulmonary disease, PAD, type 2 diabetes, right 5th toe amputation, hypertension, hyperlipidemia.  Presented with worsening lower extremity swelling, abdominal swelling, shortness of breath and decreased urine output onset 1 week prior when he ran out of metolazone. Troponin was elevated but near baseline.  EKG showed similar changes to previous.  ProBNP markedly elevated. Chest x-ray showed pulmonary vascular congestion and cardiomegaly.  Creatinine increased from baseline.  No osteomyelitis on right foot.  He was stable on 2 L nasal cannula.  Admitted to medicine for further management.     Nephrology and Cardiology were consulted.  Attempted to diurese patient aggressively was IV Lasix, then Lasix drip, then Bumex and combination of other meds.  Did not show much progress and remained fluid overloaded.  Patient complained periodically of edematous and painful scrotum.  Urology was consulted for evaluation.  CT scan and ultrasound was negative for tissue infection or abscess.  Pain likely due to edema.  Per Nephrology, dialysis was started on August 22nd with uncertain final duration. Patient was discharged with arrangements for outpatient dialysis. His course was complicated by non-adherence to recommended low Na, fluid restricted diet.   Patient also tested positive for COVID on August 20th and developed acute hypoxic respiratory failure, treated with Decadron and remdesivir.  Also noted Staph epidermidis bacteremia at the same time, ID consulted and he was placed on empiric antibiotics, ultimately transitioned to vancomycin. TEE on 8/30 negative for endocarditis. ID recommending total 4 weeks of IV vancomycin, arranged to be given with outpatient dialysis with nephrology prescribing.   Patient developed an abscess on left forearm due to infiltrated IV, which was drained by general surgery without complication.   On 9/11, patient developed left eye blurry vision. CT head and CTA head were negative for etiology, ophthalmology consulted and diagnosed with vitreous hemorrhage, recommended outpatient follow up.    Patient was discharged in stable condition with arrangements for outpatient dialysis and vancomycin to be administered at dialysis.
Age: 47.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Condition aggravated, Dialysis, Dyspnoea, Echocardiogram normal, Electrocardiogram abnormal
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 8/13/2022 Discharge Date: Sep 12, 2022  PRESENTING PROBLEM: Heart failure (HCC) [I50.9] Elevated troponin [R77.8] Acute on chronic combined systolic and diastolic congestive heart failure (HCC) [I50.43] Chronic kidney disease, stage 4 (severe) (HCC) [N18.4]   HOSPITAL COURSE: 48-year-old male admitted on 8/13/2022, with PMhx of combined heart failure, CAD post CABG, CKD stage 4, chronic obstructive pulmonary disease, PAD, type 2 diabetes, right 5th toe amputation, hypertension, hyperlipidemia.  Presented with worsening lower extremity swelling, abdominal swelling, shortness of breath and decreased urine output onset 1 week prior when he ran out of metolazone. Troponin was elevated but near baseline.  EKG showed similar changes to previous.  ProBNP markedly elevated. Chest x-ray showed pulmonary vascular congestion and cardiomegaly.  Creatinine increased from baseline.  No osteomyelitis on right foot.  He was stable on 2 L nasal cannula.  Admitted to medicine for further management.     Nephrology and Cardiology were consulted.  Attempted to diurese patient aggressively was IV Lasix, then Lasix drip, then Bumex and combination of other meds.  Did not show much progress and remained fluid overloaded.  Patient complained periodically of edematous and painful scrotum.  Urology was consulted for evaluation.  CT scan and ultrasound was negative for tissue infection or abscess.  Pain likely due to edema.  Per Nephrology, dialysis was started on August 22nd with uncertain final duration. Patient was discharged with arrangements for outpatient dialysis. His course was complicated by non-adherence to recommended low Na, fluid restricted diet.   Patient also tested positive for COVID on August 20th and developed acute hypoxic respiratory failure, treated with Decadron and remdesivir.  Also noted Staph epidermidis bacteremia at the same time, ID consulted and he was placed on empiric antibiotics, ultimately transitioned to vancomycin. TEE on 8/30 negative for endocarditis. ID recommending total 4 weeks of IV vancomycin, arranged to be given with outpatient dialysis with nephrology prescribing.   Patient developed an abscess on left forearm due to infiltrated IV, which was drained by general surgery without complication.   On 9/11, patient developed left eye blurry vision. CT head and CTA head were negative for etiology, ophthalmology consulted and diagnosed with vitreous hemorrhage, recommended outpatient follow up.    Patient was discharged in stable condition with arrangements for outpatient dialysis and vancomycin to be administered at dialysis.
Age: 47.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Hypervolaemia, Infusion site abscess, Left ventricular failure, Peripheral swelling, Polyuria
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 8/13/2022 Discharge Date: Sep 12, 2022  PRESENTING PROBLEM: Heart failure (HCC) [I50.9] Elevated troponin [R77.8] Acute on chronic combined systolic and diastolic congestive heart failure (HCC) [I50.43] Chronic kidney disease, stage 4 (severe) (HCC) [N18.4]   HOSPITAL COURSE: 48-year-old male admitted on 8/13/2022, with PMhx of combined heart failure, CAD post CABG, CKD stage 4, chronic obstructive pulmonary disease, PAD, type 2 diabetes, right 5th toe amputation, hypertension, hyperlipidemia.  Presented with worsening lower extremity swelling, abdominal swelling, shortness of breath and decreased urine output onset 1 week prior when he ran out of metolazone. Troponin was elevated but near baseline.  EKG showed similar changes to previous.  ProBNP markedly elevated. Chest x-ray showed pulmonary vascular congestion and cardiomegaly.  Creatinine increased from baseline.  No osteomyelitis on right foot.  He was stable on 2 L nasal cannula.  Admitted to medicine for further management.     Nephrology and Cardiology were consulted.  Attempted to diurese patient aggressively was IV Lasix, then Lasix drip, then Bumex and combination of other meds.  Did not show much progress and remained fluid overloaded.  Patient complained periodically of edematous and painful scrotum.  Urology was consulted for evaluation.  CT scan and ultrasound was negative for tissue infection or abscess.  Pain likely due to edema.  Per Nephrology, dialysis was started on August 22nd with uncertain final duration. Patient was discharged with arrangements for outpatient dialysis. His course was complicated by non-adherence to recommended low Na, fluid restricted diet.   Patient also tested positive for COVID on August 20th and developed acute hypoxic respiratory failure, treated with Decadron and remdesivir.  Also noted Staph epidermidis bacteremia at the same time, ID consulted and he was placed on empiric antibiotics, ultimately transitioned to vancomycin. TEE on 8/30 negative for endocarditis. ID recommending total 4 weeks of IV vancomycin, arranged to be given with outpatient dialysis with nephrology prescribing.   Patient developed an abscess on left forearm due to infiltrated IV, which was drained by general surgery without complication.   On 9/11, patient developed left eye blurry vision. CT head and CTA head were negative for etiology, ophthalmology consulted and diagnosed with vitreous hemorrhage, recommended outpatient follow up.    Patient was discharged in stable condition with arrangements for outpatient dialysis and vancomycin to be administered at dialysis.
Age: 47.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Prohormone brain natriuretic peptide increased, Pulmonary congestion, SARS-CoV-2 test positive, Scrotal oedema, Scrotal pain
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 8/13/2022 Discharge Date: Sep 12, 2022  PRESENTING PROBLEM: Heart failure (HCC) [I50.9] Elevated troponin [R77.8] Acute on chronic combined systolic and diastolic congestive heart failure (HCC) [I50.43] Chronic kidney disease, stage 4 (severe) (HCC) [N18.4]   HOSPITAL COURSE: 48-year-old male admitted on 8/13/2022, with PMhx of combined heart failure, CAD post CABG, CKD stage 4, chronic obstructive pulmonary disease, PAD, type 2 diabetes, right 5th toe amputation, hypertension, hyperlipidemia.  Presented with worsening lower extremity swelling, abdominal swelling, shortness of breath and decreased urine output onset 1 week prior when he ran out of metolazone. Troponin was elevated but near baseline.  EKG showed similar changes to previous.  ProBNP markedly elevated. Chest x-ray showed pulmonary vascular congestion and cardiomegaly.  Creatinine increased from baseline.  No osteomyelitis on right foot.  He was stable on 2 L nasal cannula.  Admitted to medicine for further management.     Nephrology and Cardiology were consulted.  Attempted to diurese patient aggressively was IV Lasix, then Lasix drip, then Bumex and combination of other meds.  Did not show much progress and remained fluid overloaded.  Patient complained periodically of edematous and painful scrotum.  Urology was consulted for evaluation.  CT scan and ultrasound was negative for tissue infection or abscess.  Pain likely due to edema.  Per Nephrology, dialysis was started on August 22nd with uncertain final duration. Patient was discharged with arrangements for outpatient dialysis. His course was complicated by non-adherence to recommended low Na, fluid restricted diet.   Patient also tested positive for COVID on August 20th and developed acute hypoxic respiratory failure, treated with Decadron and remdesivir.  Also noted Staph epidermidis bacteremia at the same time, ID consulted and he was placed on empiric antibiotics, ultimately transitioned to vancomycin. TEE on 8/30 negative for endocarditis. ID recommending total 4 weeks of IV vancomycin, arranged to be given with outpatient dialysis with nephrology prescribing.   Patient developed an abscess on left forearm due to infiltrated IV, which was drained by general surgery without complication.   On 9/11, patient developed left eye blurry vision. CT head and CTA head were negative for etiology, ophthalmology consulted and diagnosed with vitreous hemorrhage, recommended outpatient follow up.    Patient was discharged in stable condition with arrangements for outpatient dialysis and vancomycin to be administered at dialysis.
Age: 47.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Staphylococcal bacteraemia, Staphylococcal infection, Treatment noncompliance, Troponin increased, Ultrasound scan normal
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 8/13/2022 Discharge Date: Sep 12, 2022  PRESENTING PROBLEM: Heart failure (HCC) [I50.9] Elevated troponin [R77.8] Acute on chronic combined systolic and diastolic congestive heart failure (HCC) [I50.43] Chronic kidney disease, stage 4 (severe) (HCC) [N18.4]   HOSPITAL COURSE: 48-year-old male admitted on 8/13/2022, with PMhx of combined heart failure, CAD post CABG, CKD stage 4, chronic obstructive pulmonary disease, PAD, type 2 diabetes, right 5th toe amputation, hypertension, hyperlipidemia.  Presented with worsening lower extremity swelling, abdominal swelling, shortness of breath and decreased urine output onset 1 week prior when he ran out of metolazone. Troponin was elevated but near baseline.  EKG showed similar changes to previous.  ProBNP markedly elevated. Chest x-ray showed pulmonary vascular congestion and cardiomegaly.  Creatinine increased from baseline.  No osteomyelitis on right foot.  He was stable on 2 L nasal cannula.  Admitted to medicine for further management.     Nephrology and Cardiology were consulted.  Attempted to diurese patient aggressively was IV Lasix, then Lasix drip, then Bumex and combination of other meds.  Did not show much progress and remained fluid overloaded.  Patient complained periodically of edematous and painful scrotum.  Urology was consulted for evaluation.  CT scan and ultrasound was negative for tissue infection or abscess.  Pain likely due to edema.  Per Nephrology, dialysis was started on August 22nd with uncertain final duration. Patient was discharged with arrangements for outpatient dialysis. His course was complicated by non-adherence to recommended low Na, fluid restricted diet.   Patient also tested positive for COVID on August 20th and developed acute hypoxic respiratory failure, treated with Decadron and remdesivir.  Also noted Staph epidermidis bacteremia at the same time, ID consulted and he was placed on empiric antibiotics, ultimately transitioned to vancomycin. TEE on 8/30 negative for endocarditis. ID recommending total 4 weeks of IV vancomycin, arranged to be given with outpatient dialysis with nephrology prescribing.   Patient developed an abscess on left forearm due to infiltrated IV, which was drained by general surgery without complication.   On 9/11, patient developed left eye blurry vision. CT head and CTA head were negative for etiology, ophthalmology consulted and diagnosed with vitreous hemorrhage, recommended outpatient follow up.    Patient was discharged in stable condition with arrangements for outpatient dialysis and vancomycin to be administered at dialysis.
Age: 47.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Urine output decreased, Vision blurred, Vitreous haemorrhage
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 8/13/2022 Discharge Date: Sep 12, 2022  PRESENTING PROBLEM: Heart failure (HCC) [I50.9] Elevated troponin [R77.8] Acute on chronic combined systolic and diastolic congestive heart failure (HCC) [I50.43] Chronic kidney disease, stage 4 (severe) (HCC) [N18.4]   HOSPITAL COURSE: 48-year-old male admitted on 8/13/2022, with PMhx of combined heart failure, CAD post CABG, CKD stage 4, chronic obstructive pulmonary disease, PAD, type 2 diabetes, right 5th toe amputation, hypertension, hyperlipidemia.  Presented with worsening lower extremity swelling, abdominal swelling, shortness of breath and decreased urine output onset 1 week prior when he ran out of metolazone. Troponin was elevated but near baseline.  EKG showed similar changes to previous.  ProBNP markedly elevated. Chest x-ray showed pulmonary vascular congestion and cardiomegaly.  Creatinine increased from baseline.  No osteomyelitis on right foot.  He was stable on 2 L nasal cannula.  Admitted to medicine for further management.     Nephrology and Cardiology were consulted.  Attempted to diurese patient aggressively was IV Lasix, then Lasix drip, then Bumex and combination of other meds.  Did not show much progress and remained fluid overloaded.  Patient complained periodically of edematous and painful scrotum.  Urology was consulted for evaluation.  CT scan and ultrasound was negative for tissue infection or abscess.  Pain likely due to edema.  Per Nephrology, dialysis was started on August 22nd with uncertain final duration. Patient was discharged with arrangements for outpatient dialysis. His course was complicated by non-adherence to recommended low Na, fluid restricted diet.   Patient also tested positive for COVID on August 20th and developed acute hypoxic respiratory failure, treated with Decadron and remdesivir.  Also noted Staph epidermidis bacteremia at the same time, ID consulted and he was placed on empiric antibiotics, ultimately transitioned to vancomycin. TEE on 8/30 negative for endocarditis. ID recommending total 4 weeks of IV vancomycin, arranged to be given with outpatient dialysis with nephrology prescribing.   Patient developed an abscess on left forearm due to infiltrated IV, which was drained by general surgery without complication.   On 9/11, patient developed left eye blurry vision. CT head and CTA head were negative for etiology, ophthalmology consulted and diagnosed with vitreous hemorrhage, recommended outpatient follow up.    Patient was discharged in stable condition with arrangements for outpatient dialysis and vancomycin to be administered at dialysis.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Rec'd Pfizer COVID 19 booster
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient got Monovalent Moderna instead of Bivalent
Age: 0.25
Sex: F
Vaccine: COVID19-2
Symptoms: Chest pain, Electrocardiogram normal
Clinical narrative: 15 minutes after patient received her Covid Booster she complained of chest pain, She described it as a sharp pain substernal. Pt was not in distress. She denied diaphoresis and SOB. Vitals were taken; BP 120/70, P 83, O2 99%, EKG was done, Normal Sinus Rhythm noted. NP advised pt to follow-up in the ER. Pt declined calling an ambulance, her mother transported her. ER visit was normal per pt report just gave her IV fluids and discharged.
Age: 9.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was administered an expired vaccine.
Age: 57.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Cough, Mental status changes, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Patient to ED 9/4 for altered mental status. Patient has cough noted, febrile 102.9. COVID+ 9/5, RX remdesivir for 3 days. 9/7 patient left without finishing remdesivir course.
Age: 26.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incomplete course of vaccination, No adverse event
Clinical narrative: Pt has no adverse reaction, however received the booster shot, but hasn't completed the original series prior to.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: PFIZER REGULAR SERIES GIVEN INSTEAD OF BIVALENT
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Extra dose administered, No adverse event, Product administration error
Clinical narrative: The child was accidently given 2 doses of Varicella. Proquad and a dose of Varicella was inadvertently administered to the patient during the well child visit. The error was discovered during a audit by pharmacy
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: Herpes zoster, Paraesthesia, Scab, Skin lesion
Clinical narrative: Patient developed shingles after vaccination. 9/7 vaccination around 2pm 9/8 around 5pm patient started to get a tingling feeling. 9/9-9/10 sores started to develop. 9/12 patient say family doctor and was prescribed medication (valacyclovir & prednisone taper). 9/16 sores have crusted over.
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: 5yo MALE pt received his 1st pfizer dose on 07/01/22 and his 2nd Pfizer dose on 07/22/22. Based on his age, his booster dose was supposed to be due in 5 months, Dec 2022.  However, Pt received booster dose today, 09/16/2022, 3 months too soon.  Infectious MD was notified.  Per Dr. : I do not anticipate problems but the patient should monitor for the same signs and symptoms that they would after the regular dose, and contact their PCP with any concerns. The PCP will reach out to pediatric MD if there are further questions. Contacted pt's mom, states that pt is doing well so far with no side effects or symptoms from booster dose.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test normal, Diarrhoea, Dizziness, Dysmenorrhoea, Headache
Clinical narrative: 5 days after receiving my recent booster, I started my menstrual cycle for September. My cramps were so painful that I quickly became nauseous and vomited. I also had diarrhea. Shortly after this episode, the cramps subsided enough that I could rest, but I was truly concerned I would have to call 9-1-1 as I live alone and felt like I would pass out. I had to call out of work from the pain. The rest of the day I had a horrible headache. My period has not been flowing regularly and I?ve had a lot of coagulation occurring.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypercoagulation, Impaired work ability, Menstrual disorder, Nausea, Vomiting
Clinical narrative: 5 days after receiving my recent booster, I started my menstrual cycle for September. My cramps were so painful that I quickly became nauseous and vomited. I also had diarrhea. Shortly after this episode, the cramps subsided enough that I could rest, but I was truly concerned I would have to call 9-1-1 as I live alone and felt like I would pass out. I had to call out of work from the pain. The rest of the day I had a horrible headache. My period has not been flowing regularly and I?ve had a lot of coagulation occurring.
Age: 1.17
Sex: F
Vaccine: VARCEL
Symptoms: Balance disorder, Injection site erythema, Pain in extremity, Screaming
Clinical narrative: Uncontrollable screaming, leg pain, red around injection site, balance issues
Age: 20.0
Sex: F
Vaccine: COVID19, HPV9
Symptoms: Pain in extremity, Peripheral swelling
Clinical narrative: Arm swelling and pain.
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Aortic valve incompetence, Atrioventricular septal defect, Blood pressure diastolic increased, COVID-19
Clinical narrative: Primary Care Physician at Discharge: MD  Admission Date: 7/10/2022 Discharge Date: 9/12/2022  PRESENTING PROBLEM: Unbalanced common AV canal [Q21.2] L-TGA, levo-transposition of great arteries with ventricular inversion [Q20.5] S/P right ventricle to pulmonary artery (RV-PA) conduit replacement [Z98.890]   Patient is a 7 y.o. male with heterotaxy syndrome and complex congenital heart disease including dextrocardia [I,L,L] with unbalanced left-dominant complete atrioventricular canal with hypoplastic right heart and pulmonary atresia, TAPVR, and bilateral SVC, s/p right sided bidirectional Glenn and 1.5 ventricular repair including atrioventricular canal repair, complex VSD patch, RV to PA conduit, RPA division, and fenestrated ASD closure in 2/2018. He also has a history of protein losing enteropathy, chronic diastolic heart failure, CLD/central sleep apnea, GERD, CKD, Hx thrombosis (occlusive IC thrombus), GDD, and functional asplenia and a recent admission for endocarditis with enterobacter cloacae via Karius test and completed a 4 week antibiotic course on 7/2/22.     He was readmitted on 7/10/22 for planned cardiac cath that was delayed due to AKI.  He underwent the cardiac cath for hemodynamic study on 7/14 that demonstrated significantly elevated pulmonary pressures with end diastolic pressure elevated to 20 mmHg and severe conduit stenosis with free conduit insufficiency and severe bilateral AV valve insufficiency.  Because of this, he went to OR on 7/28/22 for a redo sternotomy and replacement of his RV to PA conduit with a 21 mm pulmonary homograft with right and left atrioventricular valve repairs.    On 8/21, he tested positive for COVID with minimal symptoms (tested due to maternal illness.). He completed a 5 day course of Remedisvir per ID recommendations.
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac ventricular disorder, Catheterisation cardiac abnormal, Endocarditis, Enterobacter infection, Exposure to SARS-CoV-2
Clinical narrative: Primary Care Physician at Discharge: MD  Admission Date: 7/10/2022 Discharge Date: 9/12/2022  PRESENTING PROBLEM: Unbalanced common AV canal [Q21.2] L-TGA, levo-transposition of great arteries with ventricular inversion [Q20.5] S/P right ventricle to pulmonary artery (RV-PA) conduit replacement [Z98.890]   Patient is a 7 y.o. male with heterotaxy syndrome and complex congenital heart disease including dextrocardia [I,L,L] with unbalanced left-dominant complete atrioventricular canal with hypoplastic right heart and pulmonary atresia, TAPVR, and bilateral SVC, s/p right sided bidirectional Glenn and 1.5 ventricular repair including atrioventricular canal repair, complex VSD patch, RV to PA conduit, RPA division, and fenestrated ASD closure in 2/2018. He also has a history of protein losing enteropathy, chronic diastolic heart failure, CLD/central sleep apnea, GERD, CKD, Hx thrombosis (occlusive IC thrombus), GDD, and functional asplenia and a recent admission for endocarditis with enterobacter cloacae via Karius test and completed a 4 week antibiotic course on 7/2/22.     He was readmitted on 7/10/22 for planned cardiac cath that was delayed due to AKI.  He underwent the cardiac cath for hemodynamic study on 7/14 that demonstrated significantly elevated pulmonary pressures with end diastolic pressure elevated to 20 mmHg and severe conduit stenosis with free conduit insufficiency and severe bilateral AV valve insufficiency.  Because of this, he went to OR on 7/28/22 for a redo sternotomy and replacement of his RV to PA conduit with a 21 mm pulmonary homograft with right and left atrioventricular valve repairs.    On 8/21, he tested positive for COVID with minimal symptoms (tested due to maternal illness.). He completed a 5 day course of Remedisvir per ID recommendations.
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Heart valve replacement, Laboratory test abnormal, Pulmonary arterial pressure increased, SARS-CoV-2 test positive, Sternotomy
Clinical narrative: Primary Care Physician at Discharge: MD  Admission Date: 7/10/2022 Discharge Date: 9/12/2022  PRESENTING PROBLEM: Unbalanced common AV canal [Q21.2] L-TGA, levo-transposition of great arteries with ventricular inversion [Q20.5] S/P right ventricle to pulmonary artery (RV-PA) conduit replacement [Z98.890]   Patient is a 7 y.o. male with heterotaxy syndrome and complex congenital heart disease including dextrocardia [I,L,L] with unbalanced left-dominant complete atrioventricular canal with hypoplastic right heart and pulmonary atresia, TAPVR, and bilateral SVC, s/p right sided bidirectional Glenn and 1.5 ventricular repair including atrioventricular canal repair, complex VSD patch, RV to PA conduit, RPA division, and fenestrated ASD closure in 2/2018. He also has a history of protein losing enteropathy, chronic diastolic heart failure, CLD/central sleep apnea, GERD, CKD, Hx thrombosis (occlusive IC thrombus), GDD, and functional asplenia and a recent admission for endocarditis with enterobacter cloacae via Karius test and completed a 4 week antibiotic course on 7/2/22.     He was readmitted on 7/10/22 for planned cardiac cath that was delayed due to AKI.  He underwent the cardiac cath for hemodynamic study on 7/14 that demonstrated significantly elevated pulmonary pressures with end diastolic pressure elevated to 20 mmHg and severe conduit stenosis with free conduit insufficiency and severe bilateral AV valve insufficiency.  Because of this, he went to OR on 7/28/22 for a redo sternotomy and replacement of his RV to PA conduit with a 21 mm pulmonary homograft with right and left atrioventricular valve repairs.    On 8/21, he tested positive for COVID with minimal symptoms (tested due to maternal illness.). He completed a 5 day course of Remedisvir per ID recommendations.
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Transposition of the great vessels, Vascular graft stenosis
Clinical narrative: Primary Care Physician at Discharge: MD  Admission Date: 7/10/2022 Discharge Date: 9/12/2022  PRESENTING PROBLEM: Unbalanced common AV canal [Q21.2] L-TGA, levo-transposition of great arteries with ventricular inversion [Q20.5] S/P right ventricle to pulmonary artery (RV-PA) conduit replacement [Z98.890]   Patient is a 7 y.o. male with heterotaxy syndrome and complex congenital heart disease including dextrocardia [I,L,L] with unbalanced left-dominant complete atrioventricular canal with hypoplastic right heart and pulmonary atresia, TAPVR, and bilateral SVC, s/p right sided bidirectional Glenn and 1.5 ventricular repair including atrioventricular canal repair, complex VSD patch, RV to PA conduit, RPA division, and fenestrated ASD closure in 2/2018. He also has a history of protein losing enteropathy, chronic diastolic heart failure, CLD/central sleep apnea, GERD, CKD, Hx thrombosis (occlusive IC thrombus), GDD, and functional asplenia and a recent admission for endocarditis with enterobacter cloacae via Karius test and completed a 4 week antibiotic course on 7/2/22.     He was readmitted on 7/10/22 for planned cardiac cath that was delayed due to AKI.  He underwent the cardiac cath for hemodynamic study on 7/14 that demonstrated significantly elevated pulmonary pressures with end diastolic pressure elevated to 20 mmHg and severe conduit stenosis with free conduit insufficiency and severe bilateral AV valve insufficiency.  Because of this, he went to OR on 7/28/22 for a redo sternotomy and replacement of his RV to PA conduit with a 21 mm pulmonary homograft with right and left atrioventricular valve repairs.    On 8/21, he tested positive for COVID with minimal symptoms (tested due to maternal illness.). He completed a 5 day course of Remedisvir per ID recommendations.
Age: 23.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Dizziness, Loss of consciousness
Clinical narrative: Pt got lightheaded and lost consciousness for about 5 seconds immediately post vaccine. Pt legs elevated immediately, ice packs and water offered. Pt AXOX3, vital signs initiated and Pt reported feeling better, pt was walked over to observation for an additional 15 minute observation with a steady gait. pt left at 1434 with symptoms fully resolved and with a steady gait. Educated on S/S to seek medical attention and pt verbalized understanding.
Age: 74.0
Sex: F
Vaccine: TDAP
Symptoms: No adverse event
Clinical narrative: Patient has had no adverse effect of the vaccine as of today.
Age: 76.0
Sex: F
Vaccine: FLUA4
Symptoms: Blister, Injection site erythema, Urticaria
Clinical narrative: Patient developed hives that blistered and began oozing. She developed redness around the site the day following her influenza vaccination. She reported this to me on 9-15. I referred her to her primary provider. She stated she had already notified them a few days prior and they advised her to take Benadryl. She did report that her symptoms were resolving, but she wanted to make us aware of the event.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Blood thyroid stimulating hormone, Thyroiditis subacute, Thyroxine free, Tri-iodothyronine free, Ultrasound thyroid
Clinical narrative: Subacute thyroiditis
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram cerebral normal, Arteriogram carotid normal, COVID-19, Computerised tomogram head normal, Dizziness
Clinical narrative: Admission Date: 8/23/2022 Discharge Date: 9/5/2022  PRESENTING PROBLEM: Left-sided weakness [R53.1] Acute left-sided weakness [R53.1] Acute nonintractable headache, unspecified headache type [R51.9]   HOSPITAL COURSE:   The patient is a 66 yo woman with a history of T2DM on trulicity, HTN, fibromyalgia, who presented to hospital on 8/23/22 with headache, dizziness, and L sided numbness. On presentation she was afebrile with stable vital signs. Stroke code was activated and she underwent evaluation with CT head, CTA head/neck and CT perfusion without evidence of acute infaction. MRI brain and cspine was negative for infarct but did show previous ACDF at c5/c6 and new disc bulge at C7-T1 but no high grade stenosis. Neurology was consulted and recommended starting the patient on an asa 81mg daily due to her stroke risk factors, zio patch at discharge, and followup in stroke clinic. The patient was also noted to be covid +, which was felt to be the cause of her headache and likely her symptoms of dizziness as well. She otherwise remained on room air without SOB or hypoxia. PT/OT were consulted and recommended SAR. She was recommended to followup with her previous spine surgeon after discharge for her cervical disc disease.   Her stay in the hospital was prolonged with covid isolation precautions at the SAR facility. Discharged in a stable condition to SAR on 9/4/22 with recommendations to follow up with PCP, Neurology and her spinal surgeon.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hemiparesis, Hypoaesthesia, Intervertebral disc protrusion, Magnetic resonance imaging head abnormal
Clinical narrative: Admission Date: 8/23/2022 Discharge Date: 9/5/2022  PRESENTING PROBLEM: Left-sided weakness [R53.1] Acute left-sided weakness [R53.1] Acute nonintractable headache, unspecified headache type [R51.9]   HOSPITAL COURSE:   The patient is a 66 yo woman with a history of T2DM on trulicity, HTN, fibromyalgia, who presented to hospital on 8/23/22 with headache, dizziness, and L sided numbness. On presentation she was afebrile with stable vital signs. Stroke code was activated and she underwent evaluation with CT head, CTA head/neck and CT perfusion without evidence of acute infaction. MRI brain and cspine was negative for infarct but did show previous ACDF at c5/c6 and new disc bulge at C7-T1 but no high grade stenosis. Neurology was consulted and recommended starting the patient on an asa 81mg daily due to her stroke risk factors, zio patch at discharge, and followup in stroke clinic. The patient was also noted to be covid +, which was felt to be the cause of her headache and likely her symptoms of dizziness as well. She otherwise remained on room air without SOB or hypoxia. PT/OT were consulted and recommended SAR. She was recommended to followup with her previous spine surgeon after discharge for her cervical disc disease.   Her stay in the hospital was prolonged with covid isolation precautions at the SAR facility. Discharged in a stable condition to SAR on 9/4/22 with recommendations to follow up with PCP, Neurology and her spinal surgeon.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Magnetic resonance imaging spinal abnormal, Perfusion brain scan normal, SARS-CoV-2 test positive
Clinical narrative: Admission Date: 8/23/2022 Discharge Date: 9/5/2022  PRESENTING PROBLEM: Left-sided weakness [R53.1] Acute left-sided weakness [R53.1] Acute nonintractable headache, unspecified headache type [R51.9]   HOSPITAL COURSE:   The patient is a 66 yo woman with a history of T2DM on trulicity, HTN, fibromyalgia, who presented to hospital on 8/23/22 with headache, dizziness, and L sided numbness. On presentation she was afebrile with stable vital signs. Stroke code was activated and she underwent evaluation with CT head, CTA head/neck and CT perfusion without evidence of acute infaction. MRI brain and cspine was negative for infarct but did show previous ACDF at c5/c6 and new disc bulge at C7-T1 but no high grade stenosis. Neurology was consulted and recommended starting the patient on an asa 81mg daily due to her stroke risk factors, zio patch at discharge, and followup in stroke clinic. The patient was also noted to be covid +, which was felt to be the cause of her headache and likely her symptoms of dizziness as well. She otherwise remained on room air without SOB or hypoxia. PT/OT were consulted and recommended SAR. She was recommended to followup with her previous spine surgeon after discharge for her cervical disc disease.   Her stay in the hospital was prolonged with covid isolation precautions at the SAR facility. Discharged in a stable condition to SAR on 9/4/22 with recommendations to follow up with PCP, Neurology and her spinal surgeon.
Age: 45.0
Sex: F
Vaccine: COVID19-2
Symptoms: Erythema, Peripheral swelling, Pruritus, Skin warm
Clinical narrative: Large, red, raised, swollen, hot, itchy lump on arm for 4 days.
Age: 39.0
Sex: U
Vaccine: SMALLMNK
Symptoms: Loss of consciousness, Presyncope
Clinical narrative: The patient had vasovagal reaction due to fear of needle. Patient assisted and attended to as needed per protocol. The patient was placed on flat surface and legs were elevated, cold cool packs provided to patient. Patient regained consciousness after approximate 10 seconds. Patient's vital signs were obtained 3 times every 5 minutes. Vital signs were stable. Patient was provided with water.
Age: 1.25
Sex: M
Vaccine: HEPA, HIBV, PNC13
Symptoms: No adverse event, Product preparation error
Clinical narrative: Hib (ActHIB) was reconstituted with a single vial of sterile water instead of the 0.4% sodium chloride diluent that comes with the vaccine. No adverse effects, signs or symptoms were shown by patient.
Age: 56.0
Sex: F
Vaccine: COVID19-2, FLU4, HEPA
Symptoms: Chest discomfort, Speech disorder, Wheezing
Clinical narrative: chest tightness, wheezy feeling, trouble talking.  treated with epi and benadryl and symptoms improved.  pt monitored for 3 hours and departed. .
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: COVID-19 mRNA Pfizer gray top monovalent dose ordered, dispensed, and administered. Upon later review, noticed patient had already received 3 mRNA vaccine doses previously and should have received a bivalent booster.
Age: 1.25
Sex: F
Vaccine: HEPA, HIBV, PNC13
Symptoms: No adverse event, Product preparation error
Clinical narrative: Hib (ActHIB) was reconstituted with a single vial of sterile water instead of the 0.4% sodium chloride diluent that comes with the vaccine. No adverse effects, signs or symptoms were shown by patient.
Age: 47.0
Sex: F
Vaccine: COVID19-2
Symptoms: Lymphadenopathy
Clinical narrative: Pt states she has a dove/grapefruit size swollen lymph node under left axilla.  Pt has received 2 doses of J&J previously - received the bivalent dose of Pfizer that caused this reaction. Occurred on same side as the vaccine that was given.
Age: 58.0
Sex: F
Vaccine: COVID19-2
Symptoms: Underdose
Clinical narrative: Patient only received 0.25ml for a dose.  Patient  returned on 9-16-22 and received the full 0.5ml dose.
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Headache, Hyperhidrosis, Injection site pain, Pain
Clinical narrative: Severe headache, uncontrollable chills, insane sweating, achiness, sleepiness lasting 12 hours. Pain at injection site.
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Somnolence
Clinical narrative: Severe headache, uncontrollable chills, insane sweating, achiness, sleepiness lasting 12 hours. Pain at injection site.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Monovalent Booster was given
Age: 40.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Chest pain, Dizziness, Fatigue, Immediate post-injection reaction, Nausea
Clinical narrative: Immediately after receiving vaccine patient reported symptoms of fatigue, nausea, dizziness, chest pain, palpitations and intermittent syncopial episodes.
Age: 40.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Palpitations, Syncope
Clinical narrative: Immediately after receiving vaccine patient reported symptoms of fatigue, nausea, dizziness, chest pain, palpitations and intermittent syncopial episodes.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Parosmia, SARS-CoV-2 test negative
Clinical narrative: 1ST SHOT ASMOSIA 2ND SHOT PAROSMIA
Age: 74.0
Sex: M
Vaccine: COVID19-2
Symptoms: Underdose
Clinical narrative: Patient was given the dose of 0.25ml on 9/14/22. They returned and received a full dose of  0.5ml on 9/16/22.
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Pt is 6 year old male who received the Moderna 6m-5year dose of vaccine. Pt had no adverse reaction. Monitored pt for 15 minutes after injection. Informed pt mother of adverse event.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Monovalent Booster was given
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Monovalent Booster was given
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: I tested positive for COVID-19 on August 26, 2022. I had a runny nose and sore throat. I went into the Urgent care that same day and took a PCR COVID-19 test and it came back positive. They prescribe me 6 packs of Paxlovid. I did not take the Paxlovid. Felt much better on day three and by the end of the week, I was back to normal.
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect dose administered
Clinical narrative: Patient was given 0.25ml on 9/14/22, and came back to receive the full dose on 9/16/22 of 0.5ml.
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Monovalent Booster was given
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: pt in a SNF; pt had a positive COVID test on 1/9/22 in the facility; treated with ABX; O2 via NC; pt passed away in the facility
Age: 71.0
Sex: M
Vaccine: COVID19-2
Symptoms: Injection site pain
Clinical narrative: Sore at injection site
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Monovalent booster was given
Age: 82.0
Sex: F
Vaccine: COVID19-2
Symptoms: Underdose
Clinical narrative: Patient received dose of 0.25ml on 9/14/22.  Came back on 9/16/22 and received 0.5ml, full dose.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram, Blood test abnormal, C-reactive protein increased, Magnetic resonance imaging, Ocular hyperaemia
Clinical narrative: It started with 2+ Disc Edema followed by 22 days of low grade fever and a lose of 17 pounds. Sysmptoms that followed include red eye (Scleritis) and shaking hands.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Oedema, Pyrexia, Red blood cell sedimentation rate increased, Scleritis, Tremor
Clinical narrative: It started with 2+ Disc Edema followed by 22 days of low grade fever and a lose of 17 pounds. Sysmptoms that followed include red eye (Scleritis) and shaking hands.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Venogram, Weight decreased
Clinical narrative: It started with 2+ Disc Edema followed by 22 days of low grade fever and a lose of 17 pounds. Sysmptoms that followed include red eye (Scleritis) and shaking hands.
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect dose administered
Clinical narrative: Patient was given 0.25ml on 9/14/22. Returned on 9/16/22 for the full 0.5ml dose.